Medherant Ltd   Report issue

For profit Phase 1
Founded: Coventry United Kingdom (2015)
Status: No NME R&D (2015)

Organization Overview

First Clinical Trial
2018
NCT03639571
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Medherant Ltd

Active Ingredients

Drugs in Phase 1 Trials (1)

ibuprofen (motrin) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tissue Adhesions (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1